IP Verse

Use Of Dpp Iv Inhibitors

Patent No. EP2397142 (titled "Use Of Dpp Iv Inhibitors") was filed by Boehringer Ingelheim on May 3, 2007. The application was issued on Jul 27, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKApr 27, 2023ELKINGTON AND FIFE
STADA ARZNEIMITTELApr 26, 2023KERNEBECK
KRAUS & LEDERER PARTGMBBApr 25, 2023KRAUS & LEDERER PARTGMBB
POLPHARMAApr 19, 2023HAMM & WITTKOPP
SANDOZApr 13, 2023ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2397142

BOEHRINGER INGELHEIM
Application Number
EP11179908A
Filing Date
May 3, 2007
Status
Revoked
May 29, 2025
Publication Date
Jul 27, 2022
External Links
Slate, Register , Google Patents